Liquidia Corporation
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
Mentions
2 mentions · latest on 30 Apr 2026
| Q1 2026 Investor Letter | - | 30 Apr 2026 (Q1 2026) | |
| A Year of Discipline: +27.7% | - | 16 Jan 2026 |